Prosight Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-102,000
Closed -$5.26M 54
2022
Q3
$5.26M Buy
102,000
+51,300
+101% +$3.04M 2.82% 13
2022
Q2
$2.67M Buy
+50,700
New +$3.53M 2.1% 17
2020
Q2
Sell
-20,918
Closed -$301K 62
2020
Q1
$301K Buy
+20,918
New +$600K 0.14% 43

Other funds holding THC

Prosight Management's THC Position: Q4 2022 in Review

Prosight Management sold out of Tenet Healthcare (THC) in Q4 2022, closing a stake of 102,000 shares — an estimated $5.26M sold.

Prosight Management first reported a position in THC in Q1 2020 and held it in 3 quarters. The position peaked at $5.26M in Q3 2022. 355 funds tracked by Wall St. Rank hold THC as of Q4 2022.

  • Prosight Management reported no remaining Tenet Healthcare position as of Q4 2022 after selling out during the quarter.
  • Prosight Management sold 102,000 Tenet Healthcare shares in Q4 2022, an estimated $5.26M.
  • Prosight Management first reported a position in Tenet Healthcare in Q1 2020 and held it in 3 quarters.
  • Prosight Management's Tenet Healthcare position peaked at $5.26M in Q3 2022.
  • 355 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2022.

Based on Prosight Management's 13F filing for Q4 2022, filed 14 Feb 2023.